Entrectinib is administered orally in the form of capsules. The dosage and treatment schedule may vary depending on the type and severity of the cancer, as well as the patient's overall health and response to the therapy. It is important for patients to follow their healthcare provider's instructions regarding dosage and to report any side effects experienced during treatment.
